Pancreatic DiseasesREACTNCT07768384
Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study
A study testing Multimodal Postoperative Rehabilitation Program in people with Pancreatic Diseases, run by IRCCS San Raffaele at 1 site in Italy.
Trial summary
The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy). Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Pancreatic Diseases
- What is being tested?
- Multimodal Postoperative Rehabilitation Program
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 40 participants
- Where
- 1 siteItaly
- Study dates
- 5 Oct 2026to 31 Mar 2028
- Phase
- Interventional
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Who may be able to join
- Age ≥18 years.
- Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
- Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) >21.
Who cannot join
- Metastatic disease.
- Surgical procedures other than pancreatoduodenectomy or total pancreatectomy.
- Inability to speak Italian.
- Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language.
- Medical conditions contraindicating the rehabilitation regimen (exercise and nutritional intervention), including orthopedic or cognitive disabilities and chronic renal failure (dialysis or creatinine >250 mmol).
- Pregnancy.
Trial locations and contacts
1 site in 1 country. Contact the study team or a site near you to ask about taking part.
Italy1 site, 1 recruiting
- Recruiting
Ospedale San Raffaele
Milan
Nicolò Pecorelli, 0226436046, pecorelli.nicolo@hsr.it
About this study
The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
Postoperative complications after pancreatic surgery may result in substantial physiological and metabolic stress, leading to loss of muscle mass, malnutrition, reduced functional capacity, and delayed recovery. Although prehabilitation programs have been proposed to improve patients' functional capacity before surgery, evidence regarding structured multimodal rehabilitation after pancreatic surgery is currently lacking.
Read more
Adult patients undergoing elective proximal pancreatic resection who develop a severe postoperative complication (Comprehensive Complication Index >21) will be eligible for the study. Participants will undergo a 4-week multimodal rehabilitation program starting after hospital discharge and including individualized exercise training, nutritional therapy, and anxiety-reducing techniques. The program may be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability.
The primary objective is to assess the feasibility of the rehabilitation program in terms of recruitment, adherence, completion of outcome assessments, completeness of data, and safety. Secondary objectives include evaluating postoperative functional recovery using PROMIS-29 Physical and Mental Health Summary Scores, the 6-minute walk test, and the Duke Activity Status Index. In patients with malignancy who are candidates for adjuvant treatment, return to intended oncologic treatment will also be evaluated.
A total of 40 patients will be enrolled and followed for up to 90 days after surgery.
Read the detailed description
Pancreatic surgery is associated with a high rate of postoperative morbidity. Postoperative complications may impose substantial physiological and metabolic stress, leading to depletion of functional reserves, loss of muscle mass and energy stores, malnutrition, sarcopenia, and reduced functional capacity. Recovery may be particularly prolonged in patients experiencing severe postoperative complications and in frail patients with limited physiological and metabolic reserves. Although multimodal prehabilitation has been proposed to improve functional capacity before major surgery, evidence supporting the role of structured multimodal rehabilitation in improving recovery after pancreatic resection is currently lacking.
REACT is a prospective, single-center, single-cohort, low-interventional clinical study conducted at IRCCS Ospedale San Raffaele, Milan, Italy. The study is designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection. All enrolled participants will receive the multimodal rehabilitation intervention in addition to standard postoperative care; no formal comparator group is included.
The study population will include adult patients undergoing elective proximal pancreatic resection, defined as pancreatoduodenectomy or total pancreatectomy, who develop a severe postoperative complication during their hospital stay, defined according to a Comprehensive Complication Index (CCI) >21.
The multimodal rehabilitation program will start during the first week after postoperative hospital discharge and will last 4 weeks. The intervention includes exercise training, nutritional therapy, and anxiety-reducing techniques and will be individualized according to the patient's physical, nutritional, psychological, and clinical condition. Activities will be performed under the supervision of qualified healthcare professionals, including physiotherapists, nutritionists, and psychology-trained personnel.
The exercise component will include endurance, resistance, and breathing exercises tailored to the individual patient's clinical condition. Endurance training will consist of progressively increasing moderate-intensity continuous training, with intensity adjusted according to patient performance and perceived exertion using the Borg scale. Resistance exercises will involve different upper- and lower-limb muscle groups, with progressive workload adjustments based on individual performance. The program will include two to three supervised training sessions per week, with a minimum frequency of three exercise sessions per week specified for the overall program.
Exercise rehabilitation may be delivered either in a hospital-based or home-based setting according to patient preference and availability. Hospital-based exercise sessions will be conducted in the hospital gym. For patients following the home-based program, the hospital-based intervention will be adapted while maintaining the same overall duration, therapeutic goals, and monitoring approach. Outdoor walking may replace treadmill- or cycle-based aerobic exercise when equipment is unavailable, while resistance exercises will be performed using resistance bands provided by the study center. Educational materials, video demonstrations, and monitoring devices will be provided when appropriate.
The nutritional component will consist of an individualized dietary management plan based on dietary habits, medical conditions, and nutritional status. A balanced food-based intervention will be prescribed to meet estimated caloric and nutritional requirements. A daily protein intake of 1.5-2.0 g/kg of ideal body weight will be recommended, and whey protein supplementation may be prescribed when needed. Participants will also receive instruction on anxiety-reducing strategies, including imagery, visualization, and deep-breathing techniques.
The primary objective of the study is to assess the feasibility of the 4-week multimodal rehabilitation program. Feasibility will be evaluated according to five predefined criteria: at least 50% of eligible patients agree to participate; at least 80% of enrolled patients adhere to the program; at least 80% of participants complete an outcome assessment after rehabilitation; the proportion of missing data among patients completing outcome assessments is below 10%; and no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five predefined criteria are met.
Adherence will be defined as completion of at least 80% of the planned intervention components, including exercise sessions, nutritional consultations, and psychological support sessions. For hospital-based rehabilitation, adherence will be documented by the rehabilitation team, while adherence to the home-based program will be assessed using patient diaries reviewed during regular telephone contacts. An exploratory subgroup analysis will compare feasibility outcomes between hospital-based and home-based rehabilitation.
Secondary objectives will evaluate functional recovery following surgery. Outcomes will include the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) Physical Health Summary Score and Mental Health Summary Score, the 6-minute walk test (6MWT), and the Duke Activity Status Index (DASI). Recovery will be assessed in relation to preoperative values and predefined minimal important differences. Assessments will be performed preoperatively, at hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery. In patients with malignancy who are candidates for adjuvant treatment, time to return to intended oncologic treatment (RIOT) will also be evaluated.
Safety will be assessed by monitoring, recording, and analyzing adverse events occurring during the study, with particular attention to events potentially related to exercise training, nutritional intervention, or psychological support. Routine clinical assessments performed as part of standard postoperative care will also contribute to the safety evaluation.
The planned sample size is 40 participants. Assuming an expected adherence rate of 80%, this sample size allows adherence to be estimated with a 95% confidence interval of approximately ±12 percentage points and is considered appropriate for the pilot feasibility objective of the study. Enrollment is planned over 12 months, the rehabilitation intervention will last 4 weeks, and participants will be followed for up to 3 months.
- Conditions
- Pancreatic Diseases
- Being tested
- Multimodal Postoperative Rehabilitation Program
- Keywords
- Pancreatic Surgery, Multimodal Rehabilitation, Functional Recovery, Postoperative Rehabilitation, Postoperative Complications
- Medical subject headings
- Pancreatic Diseases, Postoperative Complications
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Multimodal Postoperative Rehabilitation ProgramBehavioural
Participants will undergo a 4-week multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques. Exercise includes moderate-intensity endurance, resistance, and breathing exercises tailored to the patient's clinical condition and may be delivered in a hospital-based or home-based setting. Nutritional therapy consists of an individualized dietary plan, with a recommended protein intake of 1.5-2.0 g/kg of ideal body weight and whey protein supplementation if needed. Participants will also receive instruction in relaxation techniques, including imagery, visualization, and deep-breathing exercises. The program is delivered by qualified physiotherapists, nutritionists, and psychology-trained personnel.
| Study group | Role | What they receive |
|---|---|---|
| Multimodal Postoperative Rehabilitation | Experimental | Participants will receive a 4-week intensive multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques, tailored to each participant's clinical, physical, nutritional, and psychological condition. Exercise training will be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability. All participants will receive the multimodal rehabilitation program in addition to standard care Receives: Behavioral: Multimodal Postoperative Rehabilitation Program |
What is being measured
The primary outcome is the main question the study is designed to answer.
Feasibility of the multimodal postoperative rehabilitation program
Feasibility will be assessed according to five predefined criteria:
- ≥50% of eligible patients agree to participate;
- ≥80% of enrolled patients adhere to the program;
- ≥80% complete the post-rehabilitation outcome assessment;
- missing data among patients completing outcome assessments are <10%; (5) no serious adverse events related to the rehabilitation program occur.
The intervention will be considered feasible only if all five criteria are met.
Measured: At the end of the 4-week rehabilitation program
Secondary outcomes (4)
PROMIS-29 Physical Health Summary Score recovery
Proportion of participants who recover their preoperative PROMIS-29 Physical Health Summary Score (PHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
Measured: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
PROMIS-29 Mental Health Summary Score recovery
Proportion of participants who recover their preoperative PROMIS-29 Mental Health Summary Score (MHS) or show a decline smaller than the minimal important difference (MID) of 2.3 points.
Measured: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Six-Minute Walk Test recovery
Proportion of participants who recover their preoperative 6-minute walk test (6MWT) performance or show a decline smaller than the minimal important difference of 19 meters.
Measured: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Duke Activity Status Index recovery
Proportion of participants who recover their preoperative Duke Activity Status Index (DASI) or show a decline smaller than the minimal important difference of 6 METs.
Measured: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted17 Aug 2026
- Study start5 Oct 2026
- Primary completion30 Sep 2027 (estimated)
- Study completion31 Mar 2028 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Pancreatic DiseasesStudies of the same condition, open and under way.
- More trials run by IRCCS San RaffaeleThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- IRCCS San Raffaele
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Nicolò Pecorelli, IRCCS San Raffaele
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07768384
- Sponsor's protocol ID
- REACT
- Acronym
- REACT
- Status last verified
- Nov 2026
- First submitted
- 11 Aug 2026
- Last updated
- 3 Nov 2026
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 3 Nov 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Feasibility of a 4-Week Intensive Postoperative Multimodal Rehabilitation Program in Complicated Patients After Proximal Pancreatectomy: A Prospective Single-Cohort Study
- ClinicalTrials.gov ID
- NCT07768384
- Acronym / sponsor ID
- REACT / REACT
- Conditions
- Pancreatic Diseases
- Keywords
- Pancreatic Surgery, Multimodal Rehabilitation, Functional Recovery, Postoperative Rehabilitation, Postoperative Complications
- Study type
- Interventional
- Recruitment status
- Recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- IRCCS San RaffaeleUniversity, hospital or other
- Study start
- 5 Oct 2026 (actual)
- Primary completion
- 30 Sep 2027 (estimated)
- Study completion
- 31 Mar 2028 (estimated)
- First posted
- 17 Aug 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The REACT study is a prospective, single-center, single-cohort study designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
Postoperative complications after pancreatic surgery may result in substantial physiological and metabolic stress, leading to loss of muscle mass, malnutrition, reduced functional capacity, and delayed recovery. Although prehabilitation programs have been proposed to improve patients' functional capacity before surgery, evidence regarding structured multimodal rehabilitation after pancreatic surgery is currently lacking.
Adult patients undergoing elective proximal pancreatic resection who develop a severe postoperative complication (Comprehensive Complication Index >21) will be eligible for the study. Participants will undergo a 4-week multimodal rehabilitation program starting after hospital discharge and including individualized exercise training, nutritional therapy, and anxiety-reducing techniques. The program may be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability.
The primary objective is to assess the feasibility of the rehabilitation program in terms of recruitment, adherence, completion of outcome assessments, completeness of data, and safety. Secondary objectives include evaluating postoperative functional recovery using PROMIS-29 Physical and Mental Health Summary Scores, the 6-minute walk test, and the Duke Activity Status Index. In patients with malignancy who are candidates for adjuvant treatment, return to intended oncologic treatment will also be evaluated.
A total of 40 patients will be enrolled and followed for up to 90 days after surgery.
Detailed description
Pancreatic surgery is associated with a high rate of postoperative morbidity. Postoperative complications may impose substantial physiological and metabolic stress, leading to depletion of functional reserves, loss of muscle mass and energy stores, malnutrition, sarcopenia, and reduced functional capacity. Recovery may be particularly prolonged in patients experiencing severe postoperative complications and in frail patients with limited physiological and metabolic reserves. Although multimodal prehabilitation has been proposed to improve functional capacity before major surgery, evidence supporting the role of structured multimodal rehabilitation in improving recovery after pancreatic resection is currently lacking.
REACT is a prospective, single-center, single-cohort, low-interventional clinical study conducted at IRCCS Ospedale San Raffaele, Milan, Italy. The study is designed to evaluate the feasibility of a 4-week intensive multimodal postoperative rehabilitation program in patients who develop severe complications after proximal pancreatic resection. All enrolled participants will receive the multimodal rehabilitation intervention in addition to standard postoperative care; no formal comparator group is included.
The study population will include adult patients undergoing elective proximal pancreatic resection, defined as pancreatoduodenectomy or total pancreatectomy, who develop a severe postoperative complication during their hospital stay, defined according to a Comprehensive Complication Index (CCI) >21.
The multimodal rehabilitation program will start during the first week after postoperative hospital discharge and will last 4 weeks. The intervention includes exercise training, nutritional therapy, and anxiety-reducing techniques and will be individualized according to the patient's physical, nutritional, psychological, and clinical condition. Activities will be performed under the supervision of qualified healthcare professionals, including physiotherapists, nutritionists, and psychology-trained personnel.
The exercise component will include endurance, resistance, and breathing exercises tailored to the individual patient's clinical condition. Endurance training will consist of progressively increasing moderate-intensity continuous training, with intensity adjusted according to patient performance and perceived exertion using the Borg scale. Resistance exercises will involve different upper- and lower-limb muscle groups, with progressive workload adjustments based on individual performance. The program will include two to three supervised training sessions per week, with a minimum frequency of three exercise sessions per week specified for the overall program.
Exercise rehabilitation may be delivered either in a hospital-based or home-based setting according to patient preference and availability. Hospital-based exercise sessions will be conducted in the hospital gym. For patients following the home-based program, the hospital-based intervention will be adapted while maintaining the same overall duration, therapeutic goals, and monitoring approach. Outdoor walking may replace treadmill- or cycle-based aerobic exercise when equipment is unavailable, while resistance exercises will be performed using resistance bands provided by the study center. Educational materials, video demonstrations, and monitoring devices will be provided when appropriate.
The nutritional component will consist of an individualized dietary management plan based on dietary habits, medical conditions, and nutritional status. A balanced food-based intervention will be prescribed to meet estimated caloric and nutritional requirements. A daily protein intake of 1.5-2.0 g/kg of ideal body weight will be recommended, and whey protein supplementation may be prescribed when needed. Participants will also receive instruction on anxiety-reducing strategies, including imagery, visualization, and deep-breathing techniques.
The primary objective of the study is to assess the feasibility of the 4-week multimodal rehabilitation program. Feasibility will be evaluated according to five predefined criteria: at least 50% of eligible patients agree to participate; at least 80% of enrolled patients adhere to the program; at least 80% of participants complete an outcome assessment after rehabilitation; the proportion of missing data among patients completing outcome assessments is below 10%; and no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five predefined criteria are met.
Adherence will be defined as completion of at least 80% of the planned intervention components, including exercise sessions, nutritional consultations, and psychological support sessions. For hospital-based rehabilitation, adherence will be documented by the rehabilitation team, while adherence to the home-based program will be assessed using patient diaries reviewed during regular telephone contacts. An exploratory subgroup analysis will compare feasibility outcomes between hospital-based and home-based rehabilitation.
Secondary objectives will evaluate functional recovery following surgery. Outcomes will include the Patient-Reported Outcomes Measurement Information System-29 (PROMIS-29) Physical Health Summary Score and Mental Health Summary Score, the 6-minute walk test (6MWT), and the Duke Activity Status Index (DASI). Recovery will be assessed in relation to preoperative values and predefined minimal important differences. Assessments will be performed preoperatively, at hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery. In patients with malignancy who are candidates for adjuvant treatment, time to return to intended oncologic treatment (RIOT) will also be evaluated.
Safety will be assessed by monitoring, recording, and analyzing adverse events occurring during the study, with particular attention to events potentially related to exercise training, nutritional intervention, or psychological support. Routine clinical assessments performed as part of standard postoperative care will also contribute to the safety evaluation.
The planned sample size is 40 participants. Assuming an expected adherence rate of 80%, this sample size allows adherence to be estimated with a 95% confidence interval of approximately ±12 percentage points and is considered appropriate for the pilot feasibility objective of the study. Enrollment is planned over 12 months, the rehabilitation intervention will last 4 weeks, and participants will be followed for up to 3 months.
Study design
- Primary purpose
- Treatment
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Multimodal Postoperative Rehabilitation | Experimental | Behavioral: Multimodal Postoperative Rehabilitation ProgramParticipants will receive a 4-week intensive multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques, tailored to each participant's clinical, physical, nutritional, and psychological condition. Exercise training will be delivered either in a supervised hospital-based setting or through a home-based program according to patient preference and availability. All participants will receive the multimodal rehabilitation program in addition to standard care |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (3 listed)
- Age ≥18 years.
- Patients undergoing elective proximal pancreatic resection (pancreatoduodenectomy or total pancreatectomy).
- Patients developing a severe postoperative complication during their hospital stay, defined as a Comprehensive Complication Index (CCI) >21.
Key exclusion criteria (6 listed)
- Metastatic disease.
- Surgical procedures other than pancreatoduodenectomy or total pancreatectomy.
- Inability to speak Italian.
- Cognitive impairment or illiteracy resulting in inability to read and understand the Italian language.
- Medical conditions contraindicating the rehabilitation regimen (exercise and nutritional intervention), including orthopedic or cognitive disabilities and chronic renal failure (dialysis or creatinine >250 mmol).
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Multimodal Postoperative Rehabilitation ProgramParticipants will undergo a 4-week multimodal postoperative rehabilitation program starting during the first week after hospital discharge. The program includes individualized exercise training, nutritional therapy, and anxiety-reducing techniques. Exercise includes moderate-intensity endurance, resistance, and breathing exercises tailored to the patient's clinical condition and may be delivered in a hospital-based or home-based setting. Nutritional therapy consists of an individualized dietary plan, with a recommended protein intake of 1.5-2.0 g/kg of ideal body weight and whey protein supplementation if needed. Participants will also receive instruction in relaxation techniques, including imagery, visualization, and deep-breathing exercises. The program is delivered by qualified physiotherapists, nutritionists, and psychology-trained personnel. | Behavioural | Multimodal Postoperative Rehabilitation |
Primary outcome
Feasibility of the multimodal postoperative rehabilitation program
Time frame: At the end of the 4-week rehabilitation program
Feasibility will be assessed according to five predefined criteria: 1. ≥50% of eligible patients agree to participate; 2. ≥80% of enrolled patients adhere to the program; 3. ≥80% complete the post-rehabilitation outcome assessment; 4. missing data among patients completing outcome assessments are <10%; (5) no serious adverse events related to the rehabilitation program occur. The intervention will be considered feasible only if all five criteria are met.
4 secondary outcomes
PROMIS-29 Physical Health Summary Score recovery
Time frame: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
PROMIS-29 Mental Health Summary Score recovery
Time frame: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Six-Minute Walk Test recovery
Time frame: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Duke Activity Status Index recovery
Time frame: At hospital discharge, at the end of the 4-week rehabilitation program, and 90 days after surgery
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Nov 2026.
- Individual participant dataSharing planned: Undecided
Related trials for Pancreatic Diseases
RecruitingObservational study
Feasibility and Effectiveness of Three-day Discharge After Distal Pancreatectomy
Pancreatic Neoplasms, Distal Pancreatectomy (DP)
RecruitingPhase 1/2
VMD-928 Monotherapy and in Combination With Pembrolizumab to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
Head and Neck Carcinoma, Adenoid Cystic Carcinoma
RecruitingPhase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pheochromocytoma/Paraganglioma, Pancreatic Neuroendocrine Tumor
RecruitingPhase 1
Study of RYZ401 in Subjects With Solid Tumors Expressing SSTRs.
GEP-NET, Gastroenteropancreatic Neuroendocrine Tumor
Recruiting
The Use of Contrast Enhanced Ultrasound (CEUS) In Post-Surgical Pancreatic Cancer Patients to Evaluate Local Disease Recurrence
Pancreatic Ductal Adenocarcinoma, Pancreatic Cancer
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Multimodal Postoperative Rehabilitation Program in people with Pancreatic Diseases, run by IRCCS San Raffaele at 1 site in Italy.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 3 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: looking for participants now, as of the sponsor's last update on 3 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Italy. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Nicolò pecorelli (0226437810, pecorelli.nicolo@hsr.it), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Feasibility of the multimodal postoperative rehabilitation program (time frame: At the end of the 4-week rehabilitation program). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Nov 2026; AzTrials last refreshed its copy on 6 Nov 2026.